These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 24136657)

  • 1. Irreproducible positive results on the Cobas AmpliPrep/Cobas TaqMan HIV-1 Qual test are different qualitatively from confirmed positive results.
    Maritz J; van Zyl GU; Preiser W
    J Med Virol; 2014 Jan; 86(1):82-7. PubMed ID: 24136657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Establishing diagnostic cut-off criteria for the COBAS AmpliPrep/COBAS TaqMan HIV-1 Qualitative test through validation against the Amplicor DNA test v1.5 for infant diagnosis using dried blood spots.
    Maritz J; Preiser W; van Zyl GU
    J Clin Virol; 2012 Feb; 53(2):106-9. PubMed ID: 22196872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differentiating clearly positive from indeterminate results: A review of irreproducible HIV-1 PCR positive samples from South Africa's Early Infant Diagnosis Program, 2010-2015.
    Haeri Mazanderani A; Moyo F; Kufa T; Maritz J; Sherman GG
    Diagn Microbiol Infect Dis; 2018 Jul; 91(3):248-255. PubMed ID: 29655874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Performance of the automated COBAS AmpliPrep/COBAS TaqMan HIV-1 test on a genetically diverse panel of specimens from China: comparison to the COBAS amplicor HIV-1 monitor test, v1.5.
    Xu S; Song A; Li X; Nie J; Zhang C; Wang Y
    Intervirology; 2010; 53(4):221-8. PubMed ID: 20332651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discrepant test findings in early infant diagnosis of HIV in a national reference laboratory in Kenya: challenges and opportunities for programs.
    Kageha S; Okoth V; Kadima S; Vihenda S; Okapesi E; Nyambura E; Maiyo A; Ndung'u N; Khamadi S; Mwau M
    J Trop Pediatr; 2012 Aug; 58(4):247-52. PubMed ID: 22052701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of Roche Cobas AmpliPrep/Cobas TaqMan HIV-1 test version 2.0 (CAP/CTM v2.0) with other real-time PCR assays in HIV-1 monitoring and follow-up of low-level viral loads.
    Wojewoda CM; Spahlinger T; Harmon ML; Schnellinger B; Li Q; Dejelo C; Schmotzer C; Zhou L
    J Virol Methods; 2013 Jan; 187(1):1-5. PubMed ID: 23098667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison between the automated Roche Cobas AmpliPrep/Cobas TaqMan HIV-1 test version 2.0 assay and its version 1 and Nuclisens HIV-1 EasyQ version 2.0 assays when measuring diverse HIV-1 genotypes in China.
    Xu S; Song A; Nie J; Li X; Meng S; Zhang C; Wang Y
    J Clin Virol; 2012 Jan; 53(1):33-7. PubMed ID: 22051503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performance of a novel human immunodeficiency virus (HIV) type 1 total nucleic acid-based real-time PCR assay using whole blood and dried blood spots for diagnosis of HIV in infants.
    Stevens W; Erasmus L; Moloi M; Taleng T; Sarang S
    J Clin Microbiol; 2008 Dec; 46(12):3941-5. PubMed ID: 18923017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of dilution of plasma samples with phosphate buffered saline to eliminate the problem of small volumes associated with children infected with HIV-1 for viral load testing using Cobas AmpliPrep/COBAS TaqMan HIV-1 test, version 2.0 (CAP CTM HIV v2.0).
    Mine M; Nkoane T; Sebetso G; Sakyi B; Makhaola K; Gaolathe T
    J Virol Methods; 2013 Dec; 194(1-2):217-21. PubMed ID: 24025342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative evaluation of the Cobas Amplicor HIV-1 Monitor Ultrasensitive Test, the new Cobas AmpliPrep/Cobas Amplicor HIV-1 Monitor Ultrasensitive Test and the Versant HIV RNA 3.0 assays for quantitation of HIV-1 RNA in plasma samples.
    Berger A; Scherzed L; Stürmer M; Preiser W; Doerr HW; Rabenau HF
    J Clin Virol; 2005 May; 33(1):43-51. PubMed ID: 15797364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and outcomes of HIV-1 diagnostic challenges during universal birth testing - an urban South African observational cohort.
    Technau KG; Mazanderani AH; Kuhn L; Hans L; Strehlau R; Abrams EJ; Conradie M; Coovadia A; Mbete N; Murnane PM; Patel F; Shiau S; Tiemessen CT; Sherman GG
    J Int AIDS Soc; 2017 Aug; 20(Suppl 6):21761. PubMed ID: 28872276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of the COBAS AmpliPrep/COBAS AMPLICOR HIV-1 MONITOR Test, Version 1.5, on clinical laboratory operations.
    Germer JJ; Bendel JL; Dolenc CA; Nelson SR; Masters AL; Gerads TM; Mandrekar JN; Mitchell PS; Yao JD
    J Clin Microbiol; 2007 Sep; 45(9):3101-4. PubMed ID: 17634308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cobas p 630 instrument: a dedicated pre-analytic solution to optimize COBAS® AmpliPrep/COBAS® TaqMan® system workflow and turn-around-time.
    Vallefuoco L; Sorrentino R; Spalletti Cernia D; Colucci G; Portella G
    J Virol Methods; 2012 Dec; 186(1-2):86-8. PubMed ID: 22827959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved Sensitivity of a Dual-Target HIV-1 Qualitative Test for Plasma and Dried Blood Spots.
    Templer SP; Seiverth B; Baum P; Stevens W; Seguin-Devaux C; Carmona S
    J Clin Microbiol; 2016 Jul; 54(7):1877-1882. PubMed ID: 27194686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Results of the Abbott RealTime HIV-1 assay for specimens yielding "target not detected" results by the Cobas AmpliPrep/Cobas TaqMan HIV-1 Test.
    Babady NE; Germer JJ; Yao JD
    J Clin Microbiol; 2010 Mar; 48(3):969-71. PubMed ID: 20042629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High correlation between the Roche COBAS® AmpliPrep/COBAS® TaqMan® HIV-1, v2.0 and the Abbott m2000 RealTime HIV-1 assays for quantification of viral load in HIV-1 B and non-B subtypes.
    Karasi JC; Dziezuk F; Quennery L; Förster S; Reischl U; Colucci G; Schoener D; Seguin-Devaux C; Schmit JC
    J Clin Virol; 2011 Nov; 52(3):181-6. PubMed ID: 21813320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Performance of an Early Infant Diagnostic Test, AmpliSens DNA-HIV-FRT, Using Dried Blood Spots Collected from Children Born to Human Immunodeficiency Virus-Infected Mothers in Ukraine.
    Chang J; Tarasova T; Shanmugam V; Azarskova M; Nguyen S; Hurlston M; Sabatier J; Zhang G; Osmanov S; Ellenberger D; Yang C; Vitek C; Liulchuk M; Nizova N
    J Clin Microbiol; 2015 Dec; 53(12):3853-8. PubMed ID: 26447114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluating the performance of the GeneXpert HIV-1 qualitative assay as a consecutive test for a new early infant diagnosis algorithm in South Africa.
    Mukendi A; Kufa T; Murray T; Burke M; Strehlau R; Technau KG; Tiemessen CT; Sherman GG; Mazanderani AH
    S Afr Med J; 2021 Sep; 111(9):857-861. PubMed ID: 34949250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the QIAGEN artus HIV-1 QS-RGQ test with the Roche COBAS AmpliPrep/COBAS TaqMan HIV-1 test v2.0.
    Wall GR; Perinpanathan D; Clark DA
    J Clin Virol; 2012 Sep; 55(1):62-6. PubMed ID: 22739101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fully automated quantification of human immunodeficiency virus (HIV) type 1 RNA in human plasma by the COBAS AmpliPrep/COBAS TaqMan system.
    Schumacher W; Frick E; Kauselmann M; Maier-Hoyle V; van der Vliet R; Babiel R
    J Clin Virol; 2007 Apr; 38(4):304-12. PubMed ID: 17329164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.